A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep

W. M. Abraham, A. Ahmed, A. Cortes, M. J. Spinella, A. B. Malik, T. T. Andersen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In this study we used conscious sheep to compare the relative potencies of inhaled endothelin- (ET) 1 and ET-3 and to determine whether a newly described selective ET-1 receptor antagonist, [diaminopropionic acid1- Asp15]ET-1 ([Dpr1-Asp15]ET-1, when given as an aerosol blocks ET-1- induced bronchoconstriction. Partial concentration-response curves to ET-1 and ET-3 were obtained by measuring the change in pulmonary airflow resistance (RL) after aerosol challenge. Both ET-1 (n = 6) and ET-3 (n = 4) caused concentration-dependent (10-10-10-7) bronchoconstriction, but ET- 3 was 400-fold less potent than ET-1. Pretreatment (30 min) with 25 breaths of 5 x 10-8 M [Dpr1-Asp15]ET-1 caused a 100-fold rightward shift of the ET-1 concentration-response curve. The activity of the ET-1 antagonist (25 breaths of 5 x 10-8 M) was compared with that of various control peptides (25 breaths of 10-8 M). ET-1 (50 breaths of 10 7 M) caused an increase in RL of 133 ± 33% (SE) over baseline. [Dpr1-Asp15]ET-1 significantly inhibited this response by 54%. No protection was seen with a monocyclic control peptide or a thrombin receptor peptide. There was, however, a small protective effect (38%, P < 0.05) seen with [Dpr1-Asp15]ET-3, a structurally homologous ET-3 antagonist. [Dpr1-Asp15]ET-1 had no effect on carbachol (n = 3) or leukotriene D4-induced bronchoconstriction. Thus inhaled ET-1 and, to a lesser extent, ET-3 cause concentration-dependent bronchoconstriction in conscious sheep. The response to ET-1 can be blocked by a specific ET-1 antagonist, suggesting that this effect is mediated in part by stimulation of ET-1 receptors.

Original languageEnglish
Pages (from-to)2537-2542
Number of pages6
JournalJournal of Applied Physiology
Volume74
Issue number5
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Bronchoconstriction
Endothelin-1
Sheep
Endothelin-3
Endothelin A Receptors
Endothelin Receptor Antagonists
Aerosols
Peptides
Thrombin Receptors
Leukotriene D4
Carbachol

Keywords

  • airway pharmacology
  • asthma
  • receptors

ASJC Scopus subject areas

  • Endocrinology
  • Physiology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Abraham, W. M., Ahmed, A., Cortes, A., Spinella, M. J., Malik, A. B., & Andersen, T. T. (1993). A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. Journal of Applied Physiology, 74(5), 2537-2542.

A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. / Abraham, W. M.; Ahmed, A.; Cortes, A.; Spinella, M. J.; Malik, A. B.; Andersen, T. T.

In: Journal of Applied Physiology, Vol. 74, No. 5, 01.01.1993, p. 2537-2542.

Research output: Contribution to journalArticle

Abraham, WM, Ahmed, A, Cortes, A, Spinella, MJ, Malik, AB & Andersen, TT 1993, 'A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep', Journal of Applied Physiology, vol. 74, no. 5, pp. 2537-2542.
Abraham WM, Ahmed A, Cortes A, Spinella MJ, Malik AB, Andersen TT. A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. Journal of Applied Physiology. 1993 Jan 1;74(5):2537-2542.
Abraham, W. M. ; Ahmed, A. ; Cortes, A. ; Spinella, M. J. ; Malik, A. B. ; Andersen, T. T. / A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. In: Journal of Applied Physiology. 1993 ; Vol. 74, No. 5. pp. 2537-2542.
@article{4d6d380923354f559dc6d6aae4cec174,
title = "A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep",
abstract = "In this study we used conscious sheep to compare the relative potencies of inhaled endothelin- (ET) 1 and ET-3 and to determine whether a newly described selective ET-1 receptor antagonist, [diaminopropionic acid1- Asp15]ET-1 ([Dpr1-Asp15]ET-1, when given as an aerosol blocks ET-1- induced bronchoconstriction. Partial concentration-response curves to ET-1 and ET-3 were obtained by measuring the change in pulmonary airflow resistance (RL) after aerosol challenge. Both ET-1 (n = 6) and ET-3 (n = 4) caused concentration-dependent (10-10-10-7) bronchoconstriction, but ET- 3 was 400-fold less potent than ET-1. Pretreatment (30 min) with 25 breaths of 5 x 10-8 M [Dpr1-Asp15]ET-1 caused a 100-fold rightward shift of the ET-1 concentration-response curve. The activity of the ET-1 antagonist (25 breaths of 5 x 10-8 M) was compared with that of various control peptides (25 breaths of 10-8 M). ET-1 (50 breaths of 10 7 M) caused an increase in RL of 133 ± 33{\%} (SE) over baseline. [Dpr1-Asp15]ET-1 significantly inhibited this response by 54{\%}. No protection was seen with a monocyclic control peptide or a thrombin receptor peptide. There was, however, a small protective effect (38{\%}, P < 0.05) seen with [Dpr1-Asp15]ET-3, a structurally homologous ET-3 antagonist. [Dpr1-Asp15]ET-1 had no effect on carbachol (n = 3) or leukotriene D4-induced bronchoconstriction. Thus inhaled ET-1 and, to a lesser extent, ET-3 cause concentration-dependent bronchoconstriction in conscious sheep. The response to ET-1 can be blocked by a specific ET-1 antagonist, suggesting that this effect is mediated in part by stimulation of ET-1 receptors.",
keywords = "airway pharmacology, asthma, receptors",
author = "Abraham, {W. M.} and A. Ahmed and A. Cortes and Spinella, {M. J.} and Malik, {A. B.} and Andersen, {T. T.}",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "74",
pages = "2537--2542",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep

AU - Abraham, W. M.

AU - Ahmed, A.

AU - Cortes, A.

AU - Spinella, M. J.

AU - Malik, A. B.

AU - Andersen, T. T.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - In this study we used conscious sheep to compare the relative potencies of inhaled endothelin- (ET) 1 and ET-3 and to determine whether a newly described selective ET-1 receptor antagonist, [diaminopropionic acid1- Asp15]ET-1 ([Dpr1-Asp15]ET-1, when given as an aerosol blocks ET-1- induced bronchoconstriction. Partial concentration-response curves to ET-1 and ET-3 were obtained by measuring the change in pulmonary airflow resistance (RL) after aerosol challenge. Both ET-1 (n = 6) and ET-3 (n = 4) caused concentration-dependent (10-10-10-7) bronchoconstriction, but ET- 3 was 400-fold less potent than ET-1. Pretreatment (30 min) with 25 breaths of 5 x 10-8 M [Dpr1-Asp15]ET-1 caused a 100-fold rightward shift of the ET-1 concentration-response curve. The activity of the ET-1 antagonist (25 breaths of 5 x 10-8 M) was compared with that of various control peptides (25 breaths of 10-8 M). ET-1 (50 breaths of 10 7 M) caused an increase in RL of 133 ± 33% (SE) over baseline. [Dpr1-Asp15]ET-1 significantly inhibited this response by 54%. No protection was seen with a monocyclic control peptide or a thrombin receptor peptide. There was, however, a small protective effect (38%, P < 0.05) seen with [Dpr1-Asp15]ET-3, a structurally homologous ET-3 antagonist. [Dpr1-Asp15]ET-1 had no effect on carbachol (n = 3) or leukotriene D4-induced bronchoconstriction. Thus inhaled ET-1 and, to a lesser extent, ET-3 cause concentration-dependent bronchoconstriction in conscious sheep. The response to ET-1 can be blocked by a specific ET-1 antagonist, suggesting that this effect is mediated in part by stimulation of ET-1 receptors.

AB - In this study we used conscious sheep to compare the relative potencies of inhaled endothelin- (ET) 1 and ET-3 and to determine whether a newly described selective ET-1 receptor antagonist, [diaminopropionic acid1- Asp15]ET-1 ([Dpr1-Asp15]ET-1, when given as an aerosol blocks ET-1- induced bronchoconstriction. Partial concentration-response curves to ET-1 and ET-3 were obtained by measuring the change in pulmonary airflow resistance (RL) after aerosol challenge. Both ET-1 (n = 6) and ET-3 (n = 4) caused concentration-dependent (10-10-10-7) bronchoconstriction, but ET- 3 was 400-fold less potent than ET-1. Pretreatment (30 min) with 25 breaths of 5 x 10-8 M [Dpr1-Asp15]ET-1 caused a 100-fold rightward shift of the ET-1 concentration-response curve. The activity of the ET-1 antagonist (25 breaths of 5 x 10-8 M) was compared with that of various control peptides (25 breaths of 10-8 M). ET-1 (50 breaths of 10 7 M) caused an increase in RL of 133 ± 33% (SE) over baseline. [Dpr1-Asp15]ET-1 significantly inhibited this response by 54%. No protection was seen with a monocyclic control peptide or a thrombin receptor peptide. There was, however, a small protective effect (38%, P < 0.05) seen with [Dpr1-Asp15]ET-3, a structurally homologous ET-3 antagonist. [Dpr1-Asp15]ET-1 had no effect on carbachol (n = 3) or leukotriene D4-induced bronchoconstriction. Thus inhaled ET-1 and, to a lesser extent, ET-3 cause concentration-dependent bronchoconstriction in conscious sheep. The response to ET-1 can be blocked by a specific ET-1 antagonist, suggesting that this effect is mediated in part by stimulation of ET-1 receptors.

KW - airway pharmacology

KW - asthma

KW - receptors

UR - http://www.scopus.com/inward/record.url?scp=0027314293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027314293&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 2537

EP - 2542

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 5

ER -